nafamostat has been researched along with Acidosis, Diabetic in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mizoribine has been recognized to have an acceptable toxicity profile compared with other immunosuppressants." | 5.35 | A sudden onset of diabetic ketoacidosis and acute pancreatitis after introduction of mizoribine therapy in a patient with rheumatoid arthritis. ( Ebihara, K; Mori, S, 2008) |
| "Mizoribine has been recognized to have an acceptable toxicity profile compared with other immunosuppressants." | 1.35 | A sudden onset of diabetic ketoacidosis and acute pancreatitis after introduction of mizoribine therapy in a patient with rheumatoid arthritis. ( Ebihara, K; Mori, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, S | 1 |
| Ebihara, K | 1 |
1 other study available for nafamostat and Acidosis, Diabetic
| Article | Year |
|---|---|
A sudden onset of diabetic ketoacidosis and acute pancreatitis after introduction of mizoribine therapy in a patient with rheumatoid arthritis.
Topics: Acute Disease; Aged; Arthritis, Rheumatoid; Benzamidines; Diabetic Ketoacidosis; Drug Therapy, Combi | 2008 |